Scientists Explain Why Ovarian Cancer Stops Responding to Some Chemotherapy Treatments
News
Increased expression of the ABCB1 protein, which is known to induce resistance to Adriamycin (doxorubicin) and Abraxane (paclitaxel) in ovarian cancer patients, may also cause resistance to other ovarian cancer ... Read more